5.8
REGENERON PHARMACEUTICALS, INC. (REGN)
Health Care / Biotechnology
$755.91
Middle of the pack. No strong signal either way.
Hold
Score based on 5 of 5 models — high confidence
Key Metrics
P/E18.2ROE12.7Market Cap82B
Estimated Fair Value
$840.6010% below
Trading near or slightly below estimated fair value.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Attractive
5/9
Buffett
Attractive
Business quality & competitive moat
Graham
Neutral
36% above fair value
Lynch
Neutral
PEG 1.1 · Fast Grower
Greenblatt
Neutral
Bottom half (rank 76%)
Similar Stocks
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer